PEPTIDES
Peptide-based therapeutics are growing rapidly across metabolic, oncology, rare disease, and immunology areas. LMS supports this expansion by supplying essential peptide KSMs, protected amino acids, linkers, and complex intermediates manufactured with high precision and regulatory alignment. We provide end-to-end peptide development and cGMP scale-up, supporting programs from early discovery to clinical and commercial supply.
OUR CAPABILITIES
Specialized Peptide Building Blocks
- Protected amino acids
- Side-chain modified derivatives
- Coupling reagents
- PEG-based and non-PEG linkers
- Multi-functional scaffolds
- Complex multi-step intermediates
Fast, Flexible & Scalable Peptide Development
- Microwave-assisted crude synthesis from 0.005-5 mmol (R&D)
- Scale-up synthesis from 25-600 mmol for pilot, clinical & commercial supply
- High-throughput capability: ~1 kg every 15-45 minutes per amino acid (sequence & process dependent)
Purification & Downstream Processing
- Prep-HPLC purification with scalable method transfer
- Lyophilization for stable peptide isolation and long-term integrity
Comprehensive Analytical Services
- Physicochemical characterization
- Impurity profiling and quantitation
- In-process controls and cGMP final release testing
WHY LMS
- End-to-end capability from mg-level R&D to commercial-scale cGMP manufacturing
- Rapid microwave synthesis enabling short development cycles
- Scalable purification ensuring consistent high purity
- Robust analytical and regulatory support
- Proven experience with peptide programs in obesity & oncology
FAQs
What peptide intermediates does LMS typically produce?
Can LMS support custom-designed intermediates?
What scales can LMS manufacture peptide intermediates at?
Do you support regulatory documentation for peptide programs?
Are your facilities equipped to handle sensitive peptide chemistries?
Close